3-((6,7-Dimethoxyquinazolin-4-yl)oxy)aniline

Catalog No.: 
ACJRGC215
CAS No.: 
1188908-37-3
Molecular Formula: 
C16H15N3O3
Molecular Weight: 
297.31
3-((6,7-Dimethoxyquinazolin-4-yl)oxy)aniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$118.00InquiryInquiry
1g95%$295.00InquiryInquiry
5g95%$887.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-((6,7-Dimethoxyquinazolin-4-yl)oxy)aniline
IUPAC Name3-((6,7-dimethoxyquinazolin-4-yl)oxy)aniline
MDL No.MFCD28965408
Molecular FormulaC16H15N3O3
Molecular Weight297.31
SMILESCOC1=CC2=C(C=C1OC)C(OC3=CC=CC(N)=C3)=NC=N2
InChI KeyUZLZUPIBLLHMLD-UHFFFAOYSA-N
Synonym3-[(6,7-dimethoxy-4-quinazolinyl)oxy]aniline;3-((6,7-Dimethoxyquinazolin-4-yl)oxy)aniline;Benzenamine, 3-[(6,7-dimethoxy-4-quinazolinyl)oxy]-
CAS No.1188908-37-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACJRGC215 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBNTR321 route compound structure diagram
    ACBNTR32113790-39-1In Stock
  2. Plus
  3. ACBKRV892 route compound structure diagram
    ACBKRV89251-81-0In Stock
  4. Then
  5. ACJRGC215 route product structure diagram
    ACJRGC2151188908-37-3
Inquiry

2. ACJRGC215 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJRGC215 route product structure diagram
    ACJRGC2151188908-37-3
Inquiry

3. ACJRGC215 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJRGC215 route product structure diagram
    ACJRGC2151188908-37-3
Inquiry

Comments (0)